Category: English

New York, NY – December 4, 2025 – Following a challenge brought by Oral Essentials, Inc., BBB National Programs’ National Advertising Division reviewed advertising claims made by Smile&Shine Essentials, Inc. for its INOPRO^® Whitening Strips, including statements regarding instant whitening, enamel safety, and no sensitivity.

Oral Essentials and Smile&Shine compete in the marketing and sales of teeth whitening strips. Oral Essentials challenged express and implied claims made on Smile&Shine’s website and on Amazon regarding the benefits, efficacy, and safety of INOPRO^® Whitening Strips.

During the inquiry, Smile&Shine informed the National Advertising Division (NAD) that it had permanently discontinued the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.

In its advertiser statement, Smile&Shine stated that it “will fully comply with the NAD decision.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.  

New York, NY – December 4, 2025 – Following a challenge brought by Novo Nordisk Inc., BBB National Programs’ National Advertising Division recommended Willow Health Services, Inc. modify or discontinue health-related claims for its compounded semaglutide products.

Willow Health is a telehealth company that markets compounded drugs to patients and physicians nationally. Willow Health’s compounded semaglutide product line includes two products: “Semaglutide Tablets” and “Semaglutide Plus,” a compounded semaglutide product for injection.

Challenger Novo Nordisk is a global pharmaceutical company specializing in obesity, diabetes care, as well as other chronic conditions, including rare diseases and cardiovascular conditions. Novo Nordisk markets the only FDA-approved semaglutide medicines, including Ozempic®, Wegovy®, and Rybelsus®. Novo Nordisk challenged Willow Health’s express and implied claims regarding its compounded semaglutide product’s claimed superiority, safety, efficacy, and health benefits.

As support for the challenged claims, Willow Health asserted that prescribing decisions made by the individual doctors who consult with each Willow customer are sufficient to substantiate its advertising. Additionally, Willow Health relied on its own statements made in disclosures that its semaglutide products have not been subjected to clinical trials assessing safety or effectiveness.

The National Advertising Division (NAD) determined that Willow Health did not provide evidence to substantiate its express claims regarding health, weight loss, implied benefits, superiority, or the establishment of efficacy. The only sources referenced by Willow Health are published studies concerning Novo Nordisk’s FDA-approved semaglutide products, which NAD found are insufficient to validate claims for compounded alternatives that differ in active pharmaceutical ingredient, formulation, and method of administration.

NAD therefore determined that Willow Health did not establish a reasonable basis for the challenged express and implied claims and recommended it discontinue or modify its advertising to avoid conveying the challenged express and implied claims.

Willow did not provide an advertiser’s statement confirming that it will comply with the NAD recommendations, indicating instead that “Willow maintains that the challenged advertising is truthful and can be substantiated, and therefore does not at this time agree to comply with NAD’s recommendations.”

Because Willow did not provide an advertiser statement confirming that it will comply with the NAD recommendations, NAD will refer Willow Health to the appropriate regulatory authorities, including the relevant state Attorneys General pursuant to Section 5.1(A) of the NAD/NARB Procedures as well as platforms on which the advertising appeared and with which NAD has a reporting relationship.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.

New York, NY – December 3, 2025 – Following a challenge from Capital One, N.A., BBB National Programs’ National Advertising Division found that certain claims for the JPMorgan Chase Bank, N.A. Chase Sapphire Reserve (CSR) credit card and Chase Sapphire Reserve for Business credit card are puffery, while others should be modified or discontinued.

Capital One and Chase are competitors that market credit cards for use by individual consumers and small businesses, including in the “premium” rewards card market.

“Most Rewarding” Claims

Capital One challenged Chase’s claims that its CSR card and CSR for Business card are the “most rewarding card” and “most rewarding business card,” respectively.

The National Advertising Division (NAD) found that Chase’s “most rewarding” claims, absent additional context tying them to specific product features or attributes, are nonactionable puffery. NAD also determined that “most rewarding” card does not convey the message that a consumer will earn the most reward points with that card.

In many contexts, however, Chase’s “most rewarding” claim is juxtaposed with and connected to specific product attributes and benefits. In these contexts, NAD determined that the claim “most rewarding” conveys the superiority message that the CSR cards’ total available suite of benefits and spending-based reward earning opportunities provide the most value to consumers.

NAD found that Chase’s methodology for totaling individual credits and privileges, combined with projected points or rewards, provided a reasonable basis for the “most rewarding” claims, but determined that Chase should disclose to consumers its basis for those claims, given the number of assumptions required in Chase’s analysis.

NAD also cautioned Chase to continually monitor the pricing and nature of the various benefits and rewards it and its competitors offer to ensure that Chase’s claims remain accurate at the time they are made.

“Over $2,500 in Annual Value” and “No Competition”

Capital One also challenged Chase’s claim “And with over $2,500 in annual value,

there’s no competition” for Chase’s CSR for Business card. NAD determined that the portion stating “over $2,500 in annual value” was supported and accompanied by conspicuous disclosures detailing included credits, values, and terms and conditions.

However, NAD determined that the claim “there’s no competition” overstates any potential superiority in the Business card relative to competitors. Therefore, NAD recommended this portion of the claim be discontinued.

“Introducing the Business Card that Gives Back All You Put In”

Capital One challenged Chase’s “Introducing the Business Card that Gives Back All You Put In” arguing that it conveyed the message that cardholders would earn a value of rewards points equivalent to their spending on the card. NAD determined that such a message was not reasonably conveyed.

During the proceeding, Chase informed NAD that it permanently discontinued its “Best Offer Ever” claim in the context of Chase’s CSR card sign-up bonus offer. NAD did not review the voluntarily discontinued claim on its merits and will treat the claim, for compliance purposes, as though NAD recommended it be modified or discontinued.

In its advertiser statement, JPMorgan Chase stated it “is pleased with NAD’s decision and will comply.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

 

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.

Contact:

Jennie Rosenberg
Media Relations
BBB National Programs
press@bbbnp.org

New York, NY – December 1, 2025 – Following a compliance review stemming from a prior decision (Case #7376) and concerns submitted by The Procter & Gamble Company (P&G), BBB National Programs’ National Advertising Division will refer Rascals International Limited to the Federal Trade Commission (FTC) for failure to comply with the National Advertising Division’s (NAD) recommendation in the underlying case.

At issue for NAD were claims regarding leak protection, customer satisfaction, and consumer reviews for Rascals brand diapers. In August 2025, P&G raised concerns about ongoing noncompliant claims appearing on Rascals’ website, and NAD requested that Rascals provide an update on its compliance efforts.

In the underlying case, NAD recommended that the claims “Parents are Happier with Rascals” and “210,000+ 5-star reviews of Rascals Products” * “Based on all reviews of Rascals diapers, training pants and wipes across websites globally, including incentivized and organic reviews” be discontinued or modified to reflect sound and credible counts of its 5-star reviews. Rascals agreed to comply with NAD’s recommendations.

NAD also noted that Rascals had agreed to permanently discontinue the claim “12 hours of advanced leak protection” and based on that representation, NAD did not review that claim on the merits.

12 Hours of Advanced Leak Protection

In general, NAD’s compliance review extends to the same or substantially similar claims to those originally challenged but does not apply to new claims. Rascals revised its leak protection claim to say “up to 12 hours of protection,” arguing that this “new” claim was not appropriate for a compliance review. NAD determined that the up to claim is in fact substantially similar to the original claim “12 hours of advanced leak protection” and therefore recommended that it be discontinued.

Parents Are Happier with Rascals

The “Parents are Happier with Rascals” appeared on Rascals’ website for five months after the initial case concluded. Website claims, particularly those on a company’s own website, can be modified more expeditiously than claims in other formats, and priority should be given to those claims among all claims that should be discontinued. Rascals indicated that the challenged claim no longer appears on the website.

“210,000 5-Star Reviews Globally”

Rascals stated that it conducted an audit and re-evaluation of its 5-star reviews and revised its “210,000+ 5-star reviews of Rascals Products” claim based on the result of its audit. NAD found the revised claim, “210,000 5-Star Reviews Globally,” to be substantially similar to the challenged claim and recommended that it be discontinued or modified to reflect sound and credible counts of its 5-star reviews.

The revised associated disclosure, “Based on all reviews of Rascals diapers, training pants and wipes across websites globally, including incentivized and organic reviews,” appears immediately adjacent to the claim. However, NAD determined that while the revised disclosure is clear and conspicuous on the Rascals website, it is neither clear nor conspicuous when appearing in the product listing, where it appears via a small, hyperlinked footnote in a block of disclosures. NAD recommended that any disclosures be clearly and conspicuously displayed on the same page and immediately adjacent to the claim they modify.

Rascals refused to comply with NAD’s recommendation concerning the “up to 12 hours of protection” claim. Consequently, NAD will refer the matter to the FTC and to the platforms on which the advertising appeared and with which NAD has a reporting relationship.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.  

New York NY – November 25, 2025 – Following a Fast-Track SWIFT challenge from The Procter & Gamble Company (P&G) regarding influencer and social media advertising for One Home Brands, Inc. d/b/a Blueland, BBB National Programs’ National Advertising Division determined that certain uses of the TikTok Shop “creator earns commission” disclosure were appropriate.

Fast-Track SWIFT is an expedited process for single-issue advertising cases reviewed by the National Advertising Division (NAD). Blueland is a household products company that competes with P&G and advertises through a variety of methods, including influencer and affiliate marketing.

The challenged social media posts were posted by individuals who promote Blueland’s cleaning products.

NAD reviewed the use of TikTok Shop by creators to promote Blueland’s cleaning products, using the “creator earns commission” disclosure as required by the TikTok platform. Based on the specific context in which the disclosure appears, for those creators who were provided free product and whose only other relationship to Blueland is to participate in the TikTok shop affiliate program, NAD found that TikTok’s automated disclosure “creator earns commission” sufficiently informs consumers that a commercial relationship exists between the creators and Blueland and that no additional disclosure is necessary.

During the proceeding, Blueland stated that it had identified certain TikTok Shop posts from four creators who may have received additional compensation based on other partnerships with Blueland separate from their participation in the TikTok Shop affiliate program and requested those creators modify their posts to include additional disclosures regarding their partnership with Blueland, or discontinue the posts.

In addition, Blueland stated it would work with past and present creators of sponsored posts to revise other challenged posts to include clear and conspicuous disclosures.

Therefore, NAD did not review the voluntarily modified or discontinued claims on their merits and will treat the claims, for compliance purposes, as though NAD recommended they be modified or discontinued.

With respect to influencers who had no material connection to Blueland, because third-party statements are not considered Blueland’s advertising, therefore, NAD did not review these claims on the merits due to lack of jurisdiction.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.  

• Campaign features Jacob Lofland and the BFGoodrich All-Terrain T/A KO3 tire
• From Co-Creator Taylor Sheridan, Season 2 of Landman is now streaming exclusively on Paramount+

GREENVILLE, S.C., Nov. 20, 2025 – BFGoodrich Tires, the pioneer of peak off-road driving performance, today announced a product integration partnership with Paramount+ and the hit TV series Landman, which returned for its second season on Nov. 16. New episodes of Landman, starring Oscar^® winner Billy Bob Thornton, are available to stream every Sunday.

Set in the lucrative, yet dangerous world of the West Texas oil industry, Landman is a story of ambition, grit and endurance, making it the perfect backdrop for BFGoodrich Tires, which are built to overcome the toughest conditions.

The partnership brings BFGoodrich into the Landman narrative in a way that’s authentic to the show’s rugged aesthetic and character-driven storytelling. After all, the tagline for the new BFGoodrich All-Terrain T/A KO3 tire is “Legendary Toughness, Made Tougher.”

“BFGoodrich Tires are engineered for people who live boldly and drive with purpose,” said Omer Waysman, vice president of marketing for Michelin North America, Inc.’s business-to-consumer products. “Partnering with Landman allows us to showcase the outstanding performance of the KO3 tire, and other Terrain Family products, in a variety of harsh terrains.”

“Ready for Anything”

The KO3 tire is displayed in a marketing campaign titled “Ready for Anything,” starring Landman’s Jacob Lofland, who plays young oilman Cooper Norris in the series. The short-form docu-style piece was shot at Henderson-Durham Ranch in Jacksboro, Texas, and was produced by Paramount Brand Studio, with a crew headed by Emmy-winning director and cinematographer Scott Duncan.

In the 90-second vignette, Lofland takes viewers along for a ride, while describing his process, character and mindset as an actor. He connects his Landman experiences to themes that genuinely fit BFGoodrich: tough enough for “The Patch,” the dynamic backdrop of Paramount’s Landman, but ready for everyday life and whatever it throws at you.

Lofland illustrates how his character embodies the spirit of “legendary toughness, made tougher” and shows respect to the Texas landscape as well as the real oilfield “roughnecks,” who find a way to handle any situation they encounter.

“Creating stories that truly resonate is central to what we do, and our partnership with BFGoodrich underscores that commitment,” said Dario Spina, CMO, Paramount Brand Studio. “With Landman so deeply connected to the terrain of West Texas, BFGoodrich’s natural off-road tire performance made the collaboration a perfect match. Together, we were able to seamlessly integrate BFGoodrich into the fabric of Landman, while also creating content that offers an added extension for fans.”

A 30-second version of the vignette first aired Sunday, Nov. 16, during the premiere of Season 2. The full 90-second vignette will appear on Landman social media channels, supported by BFGoodrich, later this month.

Product integration

The KO3 tire’s predecessor, the iconic BFGoodrich All-Terrain T/A KO2 tire, as well as the rugged BFGoodrich HD-Terrain KT tire can be seen on key vehicles during Season 2. New episodes air each week from Nov. 16, 2025, through Jan. 18, 2026.

This partnership marks a bold evolution in branded entertainment, where product and story converge to create unforgettable moments.

About Landman

Co-created by Taylor Sheridan and Christian Wallace, Landman stars Oscar^® winner Billy Bob Thornton, Oscar^® nominee Demi Moore, Oscar^® nominee Andy Garcia, Oscar^® nominee Sam Elliott, Ali Larter, Jacob Lofland, Michelle Randolph, Paulina Chávez, Kayla Wallace, Mark Collie, James Jordan and Colm Feore.

Set in the boomtowns of West Texas, Landman is a modern tale of fortune seeking amongst roughnecks and wildcat billionaires – fueling an oil boom so big it’s reshaping the climate, the economy and geopolitics.

In Season Two, as oil rises from the earth, so do secrets – and Tommy Norris’s (Thornton) breaking point may be closer than he realizes. Facing mounting pressure from M-Tex Oil, Cami Miller (Moore), and the shadow of his kin, survival in West Texas isn’t noble – it’s brutal. And sooner or later something’s got to break.

Landman is executive produced by Taylor Sheridan, David C. Glasser, David Hutkin, Ron Burkle, Bob Yari, Christian Wallace, Billy Bob Thornton, Geyer Kosinski, Michael Friedman and Stephen Kay. Dan Friedkin and Jason Hoch for Imperative Entertainment, and J.K. Nickell and Megan Creydt for Texas Monthly also executive produce. Tommy Turtle serves as co-executive producer.

The series is produced by Paramount Television Studios, 101 Studios and Sheridan’s Bosque Ranch Productions.

About Paramount+

Paramount+ is a premium streaming subscription service delivering live sports, breaking news, and a Mountain of Entertainment^™, and is a cornerstone of the Direct-to-Consumer division at Paramount, a Skydance Corporation (Nasdaq: PSKY), a leading, next‑generation global media and entertainment company. The Company’s portfolio unites legendary brands, including Paramount Pictures, Paramount Television, CBS – America’s most‑watched broadcast network, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount+, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. For more information please visit www.paramount.com.

About Paramount Television Studios

Paramount Television Studios (PTVS) is a leading content studio, developing and producing premium television programs across a wide range of platforms. The studio’s slate includes hit series such as 1923, Landman, Tulsa King, Lioness, The Agency: Central Intelligence, MobLand, Mayor of Kingstown, and School Spirits for Paramount+; Dexter: Resurrection for Showtime; The Road for CBS; Reacher, Cross, and The Runarounds for Prime Video; Foundation for Apple TV+; and Emily in Paris and XO, Kitty for Netflix. Upcoming series from PTVS include 9/12 for Paramount+; Y: Marshals for CBS; Neagley and Ride or Die for Prime Video; and Neuromancer, 12 12 12, and Brothers for Apple TV+. Paramount Television Studios is a subsidiary of Paramount, a Skydance Corporation (NASDAQ: PSKY), a leading global media and entertainment company.

About BFGoodrich Tires

BFGoodrich Tires is dedicated to providing high performance tires for those who have a passion for driving in virtually any environment. Combining technical expertise with 50 years of motorsports experience, BFGoodrich delivers tires for a full range of driving experiences from ultra-high-performance street to off-road terrain with one common theme – extreme performance. Come upgrade your performance with BFGoodrich and see where our tires can take you at BFGoodrichTires.com and BFGoodrichRacing.com, as well as on Facebook and Instagram at @BFGoodrichTires and TikTok at @BFGoodrich.

For more information, contact:

Andrew Festa

Andrew.Festa@Michelin.com

New York, NY – November 20, 2025 – Following a challenge brought by Novo Nordisk Inc., BBB National Programs’ National Advertising Division reviewed express and implied advertising claims made by Regen Doctors, Inc. for its compounded semaglutide products that appeared on Regen’s website.

Regen Doctors is a telehealth company located in Allentown, Pennsylvania that markets compounded drugs to patients and physicians in many U.S. states. Challenger Novo Nordisk is a global pharmaceutical company specializing in diabetes care as well as other chronic conditions including obesity, rare diseases, and cardiovascular conditions. Novo Nordisk markets the only FDA-approved semaglutide medicines, including Rybelsus®, Ozempic® and Wegovy®.

Novo Nordisk challenged Regen Doctors’ express and implied claims regarding its compounded semaglutide product’s claimed superiority, safety, efficacy, and health benefits.

During the inquiry, Regen Doctors informed the National Advertising Division (NAD) that it had permanently discontinued the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.  

New York, NY – November 13, 2025 – Following a challenge brought by Novo Nordisk Inc., BBB National Programs’ National Advertising Division reviewed express and implied advertising claims made by Fletcher Family Medical Center for its compounded sublingual semaglutide product, Subsema, that appeared on Fletcher’s website.

Fletcher Family Medical Center is a medical center located in Los Angeles, California thatd advertised and marketed Subsema, a compounded semaglutide product for sublingual administration. Challenger Novo Nordisk is a global pharmaceutical company specializing in diabetes care as well as other chronic conditions including obesity, rare diseases, and cardiovascular conditions. Novo Nordisk markets the only FDA-approved semaglutide medicines, including Rybelsus®, Ozempic® and Wegovy®.

Novo Nordisk challenged Fletcher’s express and implied claims regarding its compounded semaglutide product’s claimed superiority, safety, efficacy, and health benefits.

During the inquiry, Fletcher informed the National Advertising Division (NAD) that it had permanently discontinued the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.  

New York, NY – November 7, 2025 – Following a challenge submitted by Pfizer, Inc., BBB National Programs’ National Advertising Division will refer BridgeBio Pharma Inc. to the relevant government agencies for review and possible enforcement action for failure to participate in the National Advertising Division (NAD) inquiry.

Pfizer and BridgeBio sell prescription medication to treat transthyretin amyloid cardiomyopathy, a progressive and fatal disease caused by the buildup of a protein called transthyretin (TTR) in the heart and other organs.

At issue for NAD were challenged express and implied claims that BridgeBio’s Attruby product is superior to Pfizer’s Vyndamax because it offers greater TTR stabilization rates. Pfizer contends these claims are misleading, citing correspondence from the FDA.

BridgeBio declined to participate in the NAD self-regulatory process. Accordingly, NAD will refer the matter to the appropriate government agency and to the platforms on which BridgeBio’s advertising appeared and NAD has a reporting relationship.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Pursuant to NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and creating fair competition for business.

New York, NY – November 6, 2025 – A panel of BBB National Programs’ National Advertising Review Board (NARB), the appellate advertising body of BBB National Programs, has recommended that AT&T Services, Inc. modify its advertising to avoid conveying a false message regarding eligibility for an iPhone device offer.

The underlying National Advertising Division (NAD) case (#7501) was initiated by Verizon Communications Inc. under Fast-Track SWIFT, an expedited process for single-issue advertising.

In that challenge, NAD found that in the challenged “Learn how everyone gets iPhone 16 Pro on us” claim, reasonable consumers understand there are limitations to the term “everyone” but that some may interpret “everyone” to mean every person who becomes an AT&T subscriber is eligible and may be surprised that it is not everyone who gets an iPhone, but only those who subscribe to specific plans.

Therefore, NAD recommended AT&T modify its advertising to avoid conveying the message that everyone is eligible for the offer or to clearly and conspicuously disclose that although everyone can be eligible for the offer, they must subscribe to certain plans.

The NARB panel agreed with NAD’s conclusion that the challenged advertising, on its face, conveys a false message that everyone “gets” a free phone and does not clarify the message by disclosing a material limitation to the offer of a free cell phone in a clear and conspicuous manner.

The panel recommended AT&T modify its advertising to avoid conveying the message that everyone is eligible for AT&T’s free cell phone offer, or to clearly and conspicuously disclose that subscribers to value plans are not eligible or otherwise make clear the extent of plan eligibility.

In its advertiser statement, AT&T stated that it will “comply with NARB’s decision.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Review Board (NARB): The National Advertising Review Board (NARB) is the appellate body for BBB National Programs’ advertising self-regulatory programs. NARB’s panel members include 85 distinguished volunteer professionals from the national advertising industry, agencies, and public members, such as academics and former members of the public sector. NARB serves as a layer of independent industry peer review that helps engender trust and compliance in NAD, CARU, and DSSRC matters.